Fitness for 5 genes in Pontibacter actiniarum KMM 6156, DSM 19842

Add gene:

Number of genes on each side:  

Top 30 experiments (either direction), sorted by average fitness

Or view all 112 experiments or choose conditions or try the comparative fitness browser

500 ntCA264_13770 and CA264_13775 are separated by 775 nucleotidesCA264_13775 and CA264_13780 are separated by 163 nucleotidesCA264_13780 and CA264_13785 are separated by 112 nucleotidesCA264_13785 and CA264_13790 are separated by 60 nucleotides CA264_13770: CA264_13770 - DNA starvation/stationary phase protection protein, at 3,217,467 to 3,217,940 _13770 CA264_13775: CA264_13775 - hypothetical protein, at 3,218,716 to 3,220,203 _13775 CA264_13780: CA264_13780 - ribonuclease Y, at 3,220,367 to 3,221,965 _13780 CA264_13785: CA264_13785 - cell division protein ZapA, at 3,222,078 to 3,222,365 _13785 CA264_13790: CA264_13790 - hypothetical protein, at 3,222,426 to 3,222,722 _13790
Group Condition CA264_13770 CA264_13775 CA264_13780 CA264_13785 CA264_13790
stress m.b. D-Cycloserine 0.032 mg/ml -6.1 -1.3 N.D. N.D. -0.3
stress m.b. Carbenicillin 0.0015 mg/ml -0.4 -0.1 N.D. N.D. -6.7
stress m.b. D-Cycloserine 0.032 mg/ml -4.7 -1.1 N.D. N.D. -0.8
stress m.b. Thallium(I) acetate 0.0025 mg/ml -2.5 -0.4 N.D. N.D. -1.2
stress m.b. Carbenicillin 0.0015 mg/ml -0.2 -0.2 N.D. N.D. -3.3
stress m.b. Thallium(I) acetate 0.0025 mg/ml -0.8 -0.4 N.D. N.D. -2.1
stress m.b. Doxycycline hyclate 0.008 mg/ml -1.6 -0.3 N.D. N.D. -0.7
stress m.b. Doxycycline hyclate 0.008 mg/ml -1.8 -0.5 N.D. N.D. -0.1
stress m.b. Cisplatin 0.025 mg/ml -0.2 +0.1 N.D. N.D. -1.3
stress m.b. Ceftazidime 0.001 mg/ml -0.2 -0.1 N.D. N.D. -1.1
stress m.b. nitrite 30 mM +0.3 -0.1 N.D. N.D. -1.5
stress m.b. nitrite 20 mM -0.3 -0.1 N.D. N.D. -1.0
stress m.b. Spectinomycin 0.08 mg/ml -0.0 -0.4 N.D. N.D. -0.9
stress m.b. Fusidic 0.0005 mg/ml +0.1 +0.0 N.D. N.D. -1.4
stress m.b. Cisplatin 0.025 mg/ml -0.9 +0.1 N.D. N.D. -0.4
stress m.b. A22 0.04 mg/ml +0.2 -0.0 N.D. N.D. -1.3
stress m.b. Dimethyl Sulfoxide 10 vol% -0.2 +0.3 N.D. N.D. -1.2
stress m.b. Nalidixic 0.016 mg/ml +0.7 -0.1 N.D. N.D. -1.7
stress m.b. Nalidixic 0.008 mg/ml +0.2 -0.3 N.D. N.D. -0.8
stress m.b. Cobalt chloride 0.05 mM -1.0 -0.1 N.D. N.D. +0.2
stress m.b. Cobalt chloride 0.15 mM -1.0 +0.1 N.D. N.D. +0.3
stress m.b. Lomefloxacin 0.002 mM +0.4 -0.1 N.D. N.D. -0.8
stress m.b. Cisplatin 0.035 mg/ml -0.9 +0.1 N.D. N.D. +0.3
stress m.b. Nickel (II) chloride 1 mM -0.9 -0.1 N.D. N.D. +0.6
stress m.b. Vancomycin 0.016 mg/ml -0.0 +0.8 N.D. N.D. -1.1
stress m.b. Lomefloxacin 0.004 mM +0.6 +0.1 N.D. N.D. -0.8
stress m.b. Vancomycin 0.016 mg/ml -0.1 +0.7 N.D. N.D. -0.7
stress m.b. Fusidic 0.001 mg/ml +0.8 +0.3 N.D. N.D. -0.6
stress m.b. Ceftazidime 0.0005 mg/ml +0.8 -0.3 N.D. N.D. +0.4
stress m.b. Cephalothin 0.005 mg/ml -0.2 +0.3 N.D. N.D. +0.9
remove
CA264_13770
plot		 remove
CA264_13775
plot		 remove
CA264_13780		 remove
CA264_13785
plot		 remove
CA264_13790
plot